Article
M4 drug discovery: human drug predictions from integrated preclinical insights exemplified with a GLP-1R agonist
2025-11-05
Abstract excerpt
<h4>ABSTRACT</h4> A major recent breakthrough in the treatment of type 2 diabetes has been the development of glucagon-like peptide-1 receptor agonists (GLP-1RAs). However, current translational frameworks struggle to predict the clinical outcomes of these drugs from preclinical data. There are several reasons for this struggle, which are generic for many drugs: GLP-1RAs act through multi-timescale mechanisms in...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 799d4008-f154-5800-a2a2-3055176b7610
- DOI
- 10.1101/2025.11.03.686224
